HIV/HCV Coinfection: Why It Matters and What to Do about It

Publish date:
October 26, 2016
AETC Source
Southeast AETC
Link to File & Online Module

Objectives

  • Understand how HIV coinfection impacts the natural history of hepatitis C virus (HCV)
  • Describe appropriate HCV direct-acting antiviral (DAA) therapies for the treatment of HIV/HCV coinfection
  • Recognize the potential for DAA drug-drug interactions, particularly with HIV antiretroviral therapy
  • Participate in case discussions regarding HCV therapy in HIV/HCV coinfection

Presented by:

Cody A. Chastain, MD

Browse more